Cancer center seeks best treatment for aggressive lymphoma
NCT ID NCT07258680
Summary
This study aims to find the most effective and safest first treatment for peripheral T-cell lymphoma, a type of blood cancer. Researchers will compare four different chemotherapy and immunotherapy combinations used at a single cancer center. The study will look at how well each treatment works and what side effects patients experience to help doctors choose the best option for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.